Luigi Scotto

3.9k total citations
82 papers, 2.8k citations indexed

About

Luigi Scotto is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Luigi Scotto has authored 82 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Immunology and 21 papers in Oncology. Recurrent topics in Luigi Scotto's work include Histone Deacetylase Inhibitors Research (19 papers), Protein Degradation and Inhibitors (14 papers) and Ubiquitin and proteasome pathways (13 papers). Luigi Scotto is often cited by papers focused on Histone Deacetylase Inhibitors Research (19 papers), Protein Degradation and Inhibitors (14 papers) and Ubiquitin and proteasome pathways (13 papers). Luigi Scotto collaborates with scholars based in United States, Italy and Germany. Luigi Scotto's co-authors include Owen A. O’Connor, Seunghee Kim‐Schulze, Nicole Suciu‐Foca, Raffaello Cortesini, George Vlad, John S. Manavalan, Enrica Marchi, Afzal J. Naiyer, Vundavalli V. Murty and Hugo Arias‐Pulido and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Luigi Scotto

80 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigi Scotto United States 30 1.5k 1.1k 642 402 280 82 2.8k
Saïd Aoufouchi France 22 1.8k 1.2× 941 0.9× 638 1.0× 360 0.9× 443 1.6× 49 2.7k
Henry Koon United States 25 1.4k 0.9× 910 0.9× 1.3k 2.1× 270 0.7× 240 0.9× 59 2.9k
Ines Gütgemann Germany 25 1.3k 0.9× 1.2k 1.1× 1.1k 1.7× 168 0.4× 368 1.3× 60 3.0k
Mary L. Bath Australia 22 2.0k 1.3× 1.3k 1.2× 1.2k 1.8× 468 1.2× 339 1.2× 30 3.5k
Eric S. Martin United States 24 1.6k 1.0× 502 0.5× 578 0.9× 346 0.9× 386 1.4× 57 2.7k
E.-B. Bröcker Germany 22 808 0.5× 905 0.9× 915 1.4× 331 0.8× 289 1.0× 44 2.2k
Laurence Lamy United States 14 1.3k 0.8× 679 0.6× 487 0.8× 319 0.8× 337 1.2× 20 2.1k
Kathy Siminovitch Canada 19 1.2k 0.8× 782 0.7× 381 0.6× 149 0.4× 186 0.7× 32 2.0k
Marie Lia United States 11 1.3k 0.8× 642 0.6× 413 0.6× 508 1.3× 600 2.1× 17 2.2k
Giorgia Simonetti Italy 25 1.0k 0.7× 778 0.7× 520 0.8× 224 0.6× 354 1.3× 91 2.2k

Countries citing papers authored by Luigi Scotto

Since Specialization
Citations

This map shows the geographic impact of Luigi Scotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Scotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Scotto more than expected).

Fields of papers citing papers by Luigi Scotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Scotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Scotto. The network helps show where Luigi Scotto may publish in the future.

Co-authorship network of co-authors of Luigi Scotto

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Scotto. A scholar is included among the top collaborators of Luigi Scotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Scotto. Luigi Scotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Scotto, Luigi, Thomas Litman, Hu Zhu, et al.. (2023). Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms. Cancers. 15(20). 4960–4960. 1 indexed citations
3.
Scotto, Luigi, Agnès Basseville, Thomas Litman, et al.. (2023). Abstract LB_C03: Protein translation inhibition enforces histone deacetylase inhibitor activity resulting in synergistic pancreatic cancer cell death. Molecular Cancer Therapeutics. 22(12_Supplement). LB_C03–LB_C03. 1 indexed citations
4.
Litman, Thomas, Robert W. Robey, Andrés Aguilera, et al.. (2021). R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin. Molecular Cancer Research. 19(8). 1361–1374. 19 indexed citations
5.
Hosono, Naoko, et al.. (2021). Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance. BMC Cancer. 21(1). 879–879. 4 indexed citations
6.
Kalac, Matko, Shi‐Xian Deng, Luigi Scotto, et al.. (2020). N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB. iScience. 23(12). 101884–101884.
7.
8.
Amengual, Jennifer E., Sathyen A. Prabhu, Maximilian Lombardo, et al.. (2016). Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib. Clinical Cancer Research. 23(12). 3084–3096. 24 indexed citations
9.
Jain, Salvia, Kelly Zullo, Luigi Scotto, et al.. (2015). Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma. Clinical Cancer Research. 21(9). 2096–2106. 49 indexed citations
10.
Amengual, Jennifer E., Paul Johannet, Maximilian Lombardo, et al.. (2015). Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma. Clinical Cancer Research. 21(20). 4663–4675. 71 indexed citations
11.
Zullo, Kelly, Laurence Cooke, Luigi Scotto, et al.. (2015). Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma. Clinical Cancer Research. 21(18). 4097–4109. 33 indexed citations
12.
Scotto, Luigi, Marianna Kruithof‐de Julio, Luca Paoluzzi, et al.. (2012). Development and Characterization of a Novel CD19CherryLuciferase (CD19CL) Transgenic Mouse for the Preclinical Study of B-Cell Lymphomas. Clinical Cancer Research. 18(14). 3803–3811. 10 indexed citations
13.
Busino, Luca, Scott E. Millman, Luigi Scotto, et al.. (2012). Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nature Cell Biology. 14(4). 375–385. 151 indexed citations
14.
Paoluzzi, Luca, Luigi Scotto, Enrica Marchi, et al.. (2010). Romidepsin and Belinostat Synergize the Antineoplastic Effect of Bortezomib in Mantle Cell Lymphoma. Clinical Cancer Research. 16(2). 554–565. 58 indexed citations
15.
Marchi, Enrica, Luca Paoluzzi, Luigi Scotto, et al.. (2010). Pralatrexate Is Synergistic with the Proteasome Inhibitor Bortezomib in In vitro and In vivo Models of T-Cell Lymphoid Malignancies. Clinical Cancer Research. 16(14). 3648–3658. 52 indexed citations
16.
Scotto, Luigi, Gopeshwar Narayan, Subhadra V. Nandula, et al.. (2008). Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes and Cancer. 47(9). 755–765. 270 indexed citations
17.
Kim‐Schulze, Seunghee, Luigi Scotto, George Vlad, et al.. (2006). Recombinant Ig-Like Transcript 3-Fc Modulates T Cell Responses via Induction of Th Anergy and Differentiation of CD8+ T Suppressor Cells. The Journal of Immunology. 176(5). 2790–2798. 80 indexed citations
18.
Ayyoub, Maha, Naira E. Souleimanian, Emmanuelle Godefroy, et al.. (2005). A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients. Clinical Immunology. 118(2-3). 188–194. 9 indexed citations
19.
Colovai, Adriana I., John S. Manavalan, Sara Galluzzo, et al.. (2004). Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts. Transplant Immunology. 13(2). 73–82. 12 indexed citations
20.
Cianetti, L, Ugo Testa, Luigi Scotto, et al.. (1989). Three new class I HLA alleles: structure of mRNAs and alternative mechanisms of processing. Immunogenetics. 29(2). 80–91. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saïd Aoufouchi Breakdown of academic impact, for papers by Henry Koon Breakdown of academic impact, for papers by Ines Gütgemann Breakdown of academic impact, for papers by Mary L. Bath Breakdown of academic impact, for papers by Eric S. Martin Breakdown of academic impact, for papers by E.-B. Bröcker Breakdown of academic impact, for papers by Laurence Lamy Breakdown of academic impact, for papers by Kathy Siminovitch Breakdown of academic impact, for papers by Marie Lia Breakdown of academic impact, for papers by Giorgia Simonetti
Rankless by CCL
2026